Retinol (vitamin A alcohol) is necessary for normal growth and differentiation of epithelial cells. Recent reports show that retinol and synthetic derivatives may prevent preneoplastic changes caused by carcinogens in epithelial cells (1-4). RA exhibits similar properties (5, 6) as do synthetic analogs of RA (7, 8) . Specific binding proteins have been demonstrated for both retinol and RA in various tissues (9, 10) . A postulation is that both retinol and RA act through their respective binding proteins in a manner similar to that found for steroid hormones (11, 12) . Ong and co-workers (13) showed the presence of cRABP in a limited number of breast and lung tumors. but not in the surrounding noncancerous tissue. Therefore. it was of interest to determine whether this binding protein was also present in dysplastic cells.
MATERIALS AND METHODS
Chemicals.-All biochemical reagents were obtained from Sigma Chemical Co.. St. Louis. Missouri. The [I PH]RA (sp act. 1.3 Ci/mmole) was obtained from F. Hoffmann-La Roche. Ltd .. Basel. Switzerland. and was purified before each experiment. The [l PH]RA was stored in toluene at -20° C. Before use the toluene was blown off under argon and replaced by ethanol containing I mg (X-tocopherollm!. Agarose was purchased from Seakem-Biomedical. Rockland. Maine.
Preparation of cytosol.-Breast tissue specimens were obtained from patients during mastectomy and from biopsies. The tissue was morphologically characterized bv macroscopic examination at the time of surgery and b~' microscopic examination by the pathologist. The ti'ssue material was frozen immediately after excision and stored at -70° C. Subsequently. it was pulverized in liquid nitrogen. The tissue powder (1-1.5 g) was homogenized at pH 7.5 in ice-cold 50 mM Tris-HCI buffer in a ratio of I: 4 (wt/vol) and centrifuged at 105.000Xg for I hour. The supernatant fraction. containing 5-10 mg protein/mI. was recovered. Protein was determined according to the method of Lowry et al. (14) .
Assay for cRABP.-Aliquots. 250 or 500 1-'1. of the supernatant fraction were incubated at 4° C for 4 hours in the dark with an equal volume of [3H]RA (10-7 M) in the assay buffer (50 mM Tris-HCl. pH 7.5). The incubation was carried out in the presence or absence of a 200-fold excess (2XIO-5 M) of unlabeled RA. The unbound ligand was removed by treatment of the solution with 250 or 500 1-' 1 of a dextran-coated charcoal suspension (0.25% charcoal and 0.025% dextran in 50 mM Tris-HCl buffer. pH 7.5).
Sucrose gradient sedimentation.-Aliquots. 200 1-'1. of the supernatant fractions were layered on linear 5-20% sucrose gradients and centrifuged at 4° C for 16 hours at 50.000 rpm.
Agarose electrophoresis.-For the electrophoresis the method described by Wagner (15) was used. Agar was replaced by agarose because agarose has lower electroosmosis. We prepared slab gels by heating 1 g agarose in 100 ml of 50 mM Michaelis buffer. pH 8.2. The clear solution was allowed to cool to 50° C and subsequently poured in a mold containing a glass plate (9.9X8.4 cm) to support the gel. Ten wells (50 1-'1) along the center line were punched out after the gel had formed. The glass plate containing the gel was placed on a brass plate coated with Teflon. and the temperature was lowered to 0° C by a circulating cooling mixture. We obtained electrical contacts by placing buffer-soaked filter paper at the long ends of the slabs. In the chamber was 100 mM Michaelis buffer. pH 8.2. The test solution was freed from unbound [3H]RA by the above charcoal method and introduced in the center wells (2X50 I-'lIsample). Electrophoresis was performed immediately to avoid diffusion and run at 120 rnA and 230 V for 90 minutes at 4° C. For analysis of the distribution of radioactivity. we sliced the gel into squares (9X3 mm). Only the anodic part of the plate was checked for specific RA binding. The gel slices were dissolved in Instagel and counted for radioactivity. We identified the peaks by running [3H]RA and ABBREVI.\TIONS I'SEO; cRABP= cellular retinoic acid-binding protein; HSA = human serum albumin; RA = retinoic acid. 1376 Huber, Geyer, Kung, et al.
HSA plus [SH]RA simultaneously with tissue extracts incubated with radioactively labeled ligand. For the mixing experiment, a crude tumor extract (4 mg protein/ml) was mixed with a partially purified rat testis cRABP preparation (1.1 mg protein/ml) and analyzed as described above. Text- figure 2A demonstrates the sedimentation pattern and text- figure 2B shows the electrophoretic migration of cRABP obtained from a mammary tumor. With both methods, the peak characteristic for cRABP was very prominent. The peak at fraction II (text- fig.  2B ) disappeared completely with an excess of unlabeled RA. The radioactivity found in fractions 3-5 represented a mixture of free and unspecifically bound ligand to HSA.
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On agarose electrophoresis, cRABP of human origin did not migrate to the same position as did the rat testis cRABP.
Text- figure 3A demonstrates the electrophoretic profile for cRABP obtained from rat testis, and text- figure  3B shows the electrophoretic profile obtained for cRABP from human breast tumor. The maximum radioactivity in the rat testis material for cRABP was found in fraction 7 as compared to fraction II of the human sample (text- fig. 3B ). The mixing experiment suggested that cRABP from the two sources was different (text- fig. 3C ). Such a difference went undetected by sucrose gradient centrifugation of the rat testis and the human tumor extracts. The electrophoretic migration pattern of cRABP (text- fig. 3B ), obtained from a primary carcinoma, was not restricted to human breast cancer. Human uterus extracts, which contain the RA-binding protein (17) , incubated with PH]RA and subjected to agarose electrophoresis, showed the ligand specifically bound also at fraction II (results not shown). Furthermore, the electrophoretic profile of extracts from human breast tumors in stage MIl (proliferation of ductules in breast tissue plus intraductal epithelial proliferation) was the same as in the primary carcinomas (results not shown). Table I shows the distribution of cRABP in breast dysplasias, with different proliferative activities, and in primary carcinomas. In 52% of the carcinomas, cRABP 
DISCUSSION
These results add more information to our understanding of the distribution of cRABP in the different stages of breast tumor formation. In contrast to Dng et al. (13) , we found cRABP in only 52% of the invasive carcinomas examined. Therefore, cRABP cannot necessarily be called an obligatory product of carcinoma formation. Also, we detected the binding protein in less than half of the breast lesions of proliferative dysplasia (stage MIl), which are considered as being possibly precancerous. None of the tissue specimens graded MI-F, which was considered normal tissue, contained cRABP (table 1) .
Retinoids obviously influence the differentiation of epithelial cells (6, 8) . Attempts to elucidate their mode of action in relation to the occurrence of steroid receptors in breast carcinomas are in progress in this laboratory. These studies and those concerning the adenylyl cyclase protein kinase system as biochemical markers (19, 20) may provide a better understanding of the many factors influencing the development of human breast tumors.
